Researchers are conducting a trial on a new cord-blood transplant method that could treat potentially fatal metabolic conditions in unborn babies. The procedure involves injecting the fetuses with treated donor cells at 12 to 14 weeks into pregnancy. Performing the transplant before the baby is born increases the chance that the procedure would be effective, a transplant expert said.

Related Summaries